Data as of Mar 14
| +0.40 / +1.37%|
The 15 analysts offering 12-month price forecasts for Auxilium Pharmaceuticals Inc have a median target of 35.00, with a high estimate of 39.00 and a low estimate of 15.00. The median estimate represents a +18.20% increase from the last price of 29.61.
The current consensus among 15 polled investment analysts is to Buy stock in Auxilium Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.